NASDAQ:KOD (Kodiak Sciences)
About KOD
Kodiak's portfolio of candidate eye treatments centers on its innovative antibody biopolymer conjugate platform.
Kodiak Sciences (NASDAQ: KOD) Latest News
No posts found.
To make the world smarter, happier, and richer.
Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people around the world achieve their financial goals through our investing services and financial advice. Our goal is to help every Canadian achieve financial freedom.
No posts found.